Similar articles

• THE PROACTIVATOR (PLASMINOGEN?) DETERMINATION IN PLASMA DURING FIBRINOLYTIC THERAPY.

  BLIX S. BLIX S. Acta Med Scand. 1964 Nov;176:649-50. doi: 10.1111/j.0954-6820.1964.tb00669.x. Acta Med Scand. 1964. PMID: 14223542 No abstract available.
• FIBRINOLYTIC AND ESTEROLYTIC ACTIVITY OF HUMAN PLASMA.

  ADAMIS DM, MANIATIS GM. ADAMIS DM, et al. Thromb Diath Haemorrh. 1965 Jun 15;13:484-91. Thromb Diath Haemorrh. 1965. PMID: 14347870 No abstract available.
• ACTIVATION OF PARTIALLY PURIFIED PLASMINOGEN IN THE PRESENCE OF EPSILON-AMINOCAPROIC ACID. A TECHNIQUE FOR PREPARING PLASMIN FREE OF EXTRINSIC ACTIVATORS.

  DONALDSON VH. DONALDSON VH. J Lab Clin Med. 1964 Feb;63:213-23. J Lab Clin Med. 1964. PMID: 14125108 No abstract available.
• [THROMBOLYTIC THERAPY AND CHANGES IN FIBRINOLYTIC ACTIVITY].

  DOUGLAS AS, MCNICOL GP. DOUGLAS AS, et al. Recenti Prog Med. 1964 Sep;37:189-217. Recenti Prog Med. 1964. PMID: 14229145 Review. Italian. No abstract available.
• FRACTIONATION AND STANDARDIZATION OF PLASMA FIBRINOLYTIC COMPONENTS.

  MACKAY M. MACKAY M. Br Med Bull. 1964 Sep;20:189-94. doi: 10.1093/oxfordjournals.bmb.a070329. Br Med Bull. 1964. PMID: 14209757 Review. No abstract available.